Your browser doesn't support javascript.
loading
Allergen-Related Coronary Vasospasm "Kounis Syndrome" Requiring Administration of Epinephrine and a Coronary Vasodilator.
Shintani, Ryosuke; Sekino, Motohiro; Egashira, Takashi; Yano, Rintaro; Inoue, Haruka; Matsumoto, Sojiro; Higashijima, Ushio; Matsumoto, Shuhei; Yonekura, Tsuyoshi; Hara, Tetsuya.
Afiliação
  • Shintani R; Department of Anesthesia, Sasebo City General Hospital, Nagasaki, Japan.
  • Sekino M; Division of Intensive Care, Nagasaki University Hospital, Nagasaki, Japan. Electronic address: m-sekino@nagasaki-u.ac.jp.
  • Egashira T; Division of Intensive Care, Nagasaki University Hospital, Nagasaki, Japan.
  • Yano R; Division of Intensive Care, Nagasaki University Hospital, Nagasaki, Japan.
  • Inoue H; Department of Anesthesiology, Nagasaki University Hospital, Nagasaki, Japan.
  • Matsumoto S; Division of Intensive Care, Nagasaki University Hospital, Nagasaki, Japan.
  • Higashijima U; Division of Intensive Care, Nagasaki University Hospital, Nagasaki, Japan.
  • Matsumoto S; Department of Anesthesiology, Nagasaki University Hospital, Nagasaki, Japan.
  • Yonekura T; Department of Cardiology, Nagasaki University Hospital, Nagasaki, Japan.
  • Hara T; Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
J Cardiothorac Vasc Anesth ; 35(9): 2768-2771, 2021 09.
Article em En | MEDLINE | ID: mdl-32888803
ABSTRACT
Kounis syndrome is an anaphylactic reaction leading to acute coronary syndrome. The acute treatment of anaphylaxis is epinephrine; however, epinephrine may cause coronary vasoconstriction, reduce coronary blood flow, increase myocardial oxygen demand, and worsen myocardial ischemia. On the other hand, coronary vasodilation, a treatment for acute coronary syndrome, can aggravate hypotension in patients with anaphylaxis. Herein, the authors report a case of type II Kounis syndrome, with vasospasm in a patient with coronary disease, requiring the administration of epinephrine and a coronary vasodilator for resuscitation. The authors administered intravenous epinephrine continuously from lower dosages and performed delicate titration. The coronary vasodilator nicorandil, which has little effect on hemodynamics, also was administered. These treatments improved hemodynamics without complications. Circulatory management that considers both anaphylaxis and coronary lesions is crucial to improve prognosis in this syndrome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alérgenos / Vasoespasmo Coronário / Síndrome de Kounis / Anafilaxia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alérgenos / Vasoespasmo Coronário / Síndrome de Kounis / Anafilaxia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article